Skip to main content
Top

Journal of Cancer Survivorship

Issue 4/2013

Content (15 Articles)

Health-related quality of life in survivors of childhood cancer: the role of chronic health problems

Corina S. Rueegg, Micol E. Gianinazzi, Johannes Rischewski, Maja Beck Popovic, Nicolas X. von der Weid, Gisela Michel, Claudia E. Kuehni

Health-related quality of life, lifestyle behaviors, and intervention preferences of survivors of childhood cancer

Hoda Badr, Joya Chandra, Raheem J. Paxton, Joann L. Ater, Diana Urbauer, Cody Scott Cruz, Wendy Demark-Wahnefried

Risk of subsequent malignancies in survivors of childhood leukemia

Stephanie M. Perkins, Todd DeWees, Eric T. Shinohara, Mythri M. Reddy, Haydar Frangoul

Feasibility and efficacy of a supervised exercise intervention in de-conditioned cancer survivors during the early survivorship phase: the PEACH trial

J. M. Broderick, E. Guinan, M. J. Kennedy, D. Hollywood, K. S. Courneya, S. N. Culos-Reed, K. Bennett, D. M. O’ Donnell, J. Hussey

Trends in modifiable lifestyle-related risk factors following diagnosis in breast cancer survivors

Guixiang Zhao, Chaoyang Li, Catherine A. Okoro, Jun Li, Xiao Jun Wen, Arica White, Lina S. Balluz

Open Access Review

A qualitative synthesis of trials promoting physical activity behaviour change among post-treatment breast cancer survivors

Camille E. Short, Erica L. James, Fiona Stacey, Ronald C. Plotnikoff

Original Paper

Prognostic factors of work disability in sick-listed cancer survivors

Peter van Muijen, Saskia F. A. Duijts, Allard J. van der Beek, Johannes R. Anema

The impact of comorbidity on Health-Related Quality of Life among cancer survivors: analyses of data from the PROFILES registry

P. A. J. Vissers, M. S. Y. Thong, F. Pouwer, M. M. J. Zanders, J. W. W. Coebergh, L. V. van de Poll-Franse

Type of hematological malignancy is crucial for the return to work prognosis: a register-based cohort study

Trine Allerslev Horsboel, Claus Vinther Nielsen, Bendt Nielsen, Chris Jensen, Niels Trolle Andersen, Annette de Thurah

Validity of self-reported genetic counseling and genetic testing use among breast cancer survivors

Heidi A. Hamann, Jasmin A. Tiro, Joanne M. Sanders, Trisha V. Melhado, Rachel K. Funk, Melissa Y. Carpentier, L. Kay Bartholomew, Keith E. Argenbright, Sally W. Vernon

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine